Reading, United Kingdom

Mona Simonovic

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 6.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mona Simonovic: Innovator in Polymyxin Compounds

Introduction

Mona Simonovic is a notable inventor based in Reading, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of polymyxin compounds. With a total of 3 patents to her name, her work focuses on innovative methods for treating bacterial infections.

Latest Patents

Mona's latest patents include groundbreaking inventions related to polymyxin compounds. One of her notable patents describes a compound of formula (I) and its use in methods of treatment, including the treatment of bacterial infections. The invention provides methods for the preparation of this compound, which is characterized by specific amino acid residues. Another patent emphasizes the pharmaceutical compositions comprising these compounds and their application in treating microbial infections.

Career Highlights

Throughout her career, Mona has worked with several prominent companies in the pharmaceutical industry. Notable among these are Spero Therapeutics, Inc. and New Pharma Licence Holdings Limited. Her work in these organizations has contributed to advancements in medical treatments and drug development.

Collaborations

Mona has collaborated with various professionals in her field, including Pamela Brown and Michael Dawson. These collaborations have further enriched her research and development efforts.

Conclusion

Mona Simonovic stands out as an innovative inventor in the realm of polymyxin compounds, with her patents paving the way for new treatments in the fight against bacterial infections. Her contributions to the pharmaceutical industry are commendable and continue to impact medical science positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…